newsonline24

This is still a distant prospect, but the patented technology for both mobile and stationary use of such thawing devices is already here. Thawing deep-frozen plasma has been completely reimagined – with astonishingly short thawing times of 6-8 minutes without damaging the plasma. This PlasmaQuick machine represents a true leap forward in medical thawing technology. Developed for hospitals and emergency care, it combines speed, safety, and digital intelligence in a way never before achieved.

Key revolutionary features:

1. Significantly reduced thawing times: Conventional devices require 30 minutes or longer – a critical bottleneck in emergencies. PlasmaQuick achieves this in less than 8 minutes, without compromising quality or regulatory compliance.
2. Innovative technical concept: At the heart of PlasmaQuick is the agitation system, which gently moves the plasma during thawing. This ensures efficient heat transfer and even, gentle thawing – without the risks associated with microwave devices (such as clumping or loss of quality).
3. Digital integration and traceability: PlasmaQuick is fully integrated into hospital information systems, supports supply chain tracking (RFID), and enables remote maintenance and digital documentation of all process data – thus meeting the requirements of modern, digitized clinical workflows.
4. Patents and market readiness: The European patent has already been granted; Patents have been filed in the USA, China, and India. A fully functional model has been developed, on which a series of tests have already been conducted, demonstrating this leap in innovation. The next step is to develop the functional model into a market-ready prototype and partners are sought for this. Market forecasts predict above-average growth and high returns.
5. Clinical and economic impact: Hospitals can transfuse plasma faster and more safely, reduce costs and storage requirements, and minimize waste.
6. PlasmaQuick was developed for the needs of hospitals. But it is also particularly suitable for military use: Initial treatment in the field with the mobile version of PlasmaQuick (faster than instant plasma) and subsequent treatment in the hospital with the stationary device.

PlasmaQuick sets new standards in terms of thawing speed, plasma quality, digital integration, and economic benefits, thus addressing the key challenges of transfusion medicine.

Further information can be found at www.blutplasma-auftauen.de or by email at wleven@blutplasma-auftauen.de.